The expansion in Jambusar will create new jobs for around 225 employees and is part of a more than $1 billion strategic investment programme of SCHOTT through 2025
SCHOTT is investing a total of 70 million euros in the expansion of its Indian tubing site in Jambusar, Gujarat, following several million investments in the last years. “Against the backdrop of the growth trend in the Indian pharmaceutical business and the pandemic, we want to commit to secure the supply of pharma glass,” explains Dr Patrick Markschläger, Executive Vice President of SCHOTT’s Business Unit Tubing.
“The increase of over 30 per cent in the facility’s overall Indian production capacity is at the same time a commitment to supporting the government’s vision of India becoming a global pharmaceutical hub,” adds Pawan Shukla, MD, SCHOTT Glass India, during the groundbreaking event at the site.
The additional tank is scheduled to go into operation at the beginning of 2023, with the second one following a year later. The expansion in Jambusar will create new jobs for around 225 employees and is part of a more than $1 billion strategic investment programme of SCHOTT through 2025, leveraging the global pharma tubing and packaging business.
With additional melting tanks and production lines, SCHOTT intends to ensure that this Asian manufacturing hub can adequately supply high-quality pharma glass for the Indian pharma industry and neighbouring countries. The increase of melting capacities in India – supplemented by a batch house, a driveway, and a canteen for the employees – is part of SCHOTT’s commitment to invest over 100 million euros in its Indian tubing facilities and triple production capacity to produce FIOLAX glass tubing for domestic and export demands.
SCHOTT’s glass tubing (FIOLAX) is the gold standard for pharmaceutical packaging for more than a century. The material is best suited for vaccines and life-saving medications, as it avoids the interactions between containers and the drug formulation that can limit its effectiveness.
